开普敦症状性儿童中 A 组链球菌 emm 型流行率和潜在疫苗覆盖率。
Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage.
机构信息
From the *Department of Medicine, Groote Schuur Hospital and University of Cape Town; †Department of Clinical Laboratory Sciences, Division of Microbiology, National Health Service and University of Cape Town, Cape Town, South Africa; and ‡University of Tennessee Health Science Center, Memphis, TN.
出版信息
Pediatr Infect Dis J. 2014 Feb;33(2):208-10. doi: 10.1097/INF.0b013e3182a5c32a.
Abstract
The molecular epidemiology of group A streptococcal pharyngeal infections in children in the Vanguard Community of Cape Town revealed 26 emm types among 157 isolates from 742 subjects. Coverage of a 30-valent vaccine is predicted to be 95% of pharyngitis cases in this population at high risk of rheumatic fever.
摘要
在开普敦先锋社区儿童 A 组链球菌咽峡炎感染的分子流行病学研究中，从 742 名研究对象的 157 株分离株中发现了 26 种 emm 型。在该高危风湿热人群中，预计 30 价疫苗对咽峡炎病例的覆盖率为 95%。
相似文献
1
Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage.开普敦症状性儿童中 A 组链球菌 emm 型流行率和潜在疫苗覆盖率。
Pediatr Infect Dis J. 2014 Feb;33(2):208-10. doi: 10.1097/INF.0b013e3182a5c32a.
2
Changing epidemiology of acute rheumatic fever in the United States.美国急性风湿热流行病学的变化
Clin Infect Dis. 2006 Feb 15;42(4):448-50. doi: 10.1086/499817. Epub 2006 Jan 17.
3
Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development.新西兰咽炎和皮肤感染患者中化脓性链球菌的M蛋白比较分析：对疫苗开发的启示
BMC Infect Dis. 2016 Oct 12;16(1):561. doi: 10.1186/s12879-016-1891-6.
4
Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town.开普敦地区非侵袭性和侵袭性 A 组链球菌感染的分子流行病学研究
mSphere. 2019 Oct 30;4(5):e00421-19. doi: 10.1128/mSphere.00421-19.
5
The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.emm型多样性并不总是反映M蛋白的遗传多样性——是否存在针对A群链球菌的定制疫苗的情况。
Vaccine. 2010 Jan 22;28(4):883-5. doi: 10.1016/j.vaccine.2009.10.137. Epub 2009 Dec 4.
6
Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.北美儿童A组链球菌性咽炎分离株的七年监测
Clin Infect Dis. 2009 Jul 1;49(1):78-84. doi: 10.1086/599344.
7
Group A streptococcal meningitis: emm type distribution and theoretical vaccine coverage in children.A组链球菌性脑膜炎：儿童的emm型分布及理论疫苗覆盖率
Acta Clin Belg. 2016 Jun;71(3):138-41. doi: 10.1179/2295333715Y.0000000066. Epub 2016 Jun 6.
8
Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.印度北部人群中针对流行的A组链球菌M蛋白保守区肽段的免疫反应
J Microbiol Immunol Infect. 2016 Jun;49(3):352-8. doi: 10.1016/j.jmii.2014.05.008. Epub 2014 Jul 30.
9
Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal Clusters in Africa To Inform Vaccine Development.系统评价和荟萃分析非洲 A 组链球菌群的流行情况，以为疫苗开发提供信息。
mSphere. 2020 Jul 15;5(4):e00429-20. doi: 10.1128/mSphere.00429-20.
10
Prospective surveillance of streptococcal sore throat in a tropical country.热带国家链球菌性咽喉炎的前瞻性监测。
Pediatr Infect Dis J. 2009 Jun;28(6):477-82. doi: 10.1097/INF.0b013e318194b2af.
引用本文的文献
1
The Role of Physical Examination and Clinical Scores in Distinguishing Streptococcal Colonization from Pharyngitis in Pediatric Patients: Insights from a Common Clinical Scenario.体格检查和临床评分在区分儿科患者链球菌定植与咽炎中的作用：常见临床场景的见解
Microorganisms. 2025 Feb 27;13(3):529. doi: 10.3390/microorganisms13030529.
2
Serum Immune Responses to Group A Streptococcal Antigens following Pharyngeal Acquisitions among Children in Cape Town, South Africa.南非开普敦儿童咽部获得性 A 组链球菌抗原的血清免疫反应。
mSphere. 2023 Jun 22;8(3):e0011323. doi: 10.1128/msphere.00113-23. Epub 2023 May 8.
3
Pathogenesis, epidemiology and control of Group A Streptococcus infection.A 组链球菌感染的发病机制、流行病学和控制。
Nat Rev Microbiol. 2023 Jul;21(7):431-447. doi: 10.1038/s41579-023-00865-7. Epub 2023 Mar 9.
4
Diagnostic Accuracy of Centor Score for Diagnosis of Group A Streptococcal Pharyngitis among Adults in Primary Care Clinics in Malaysia.马来西亚基层医疗诊所中成人A组链球菌性咽炎诊断的Centor评分诊断准确性
Malays J Med Sci. 2022 Aug;29(4):88-97. doi: 10.21315/mjms2022.29.4.9. Epub 2022 Aug 29.
5
Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum.风湿热和风湿性心脏病连续体的最新进展
Pathogens. 2022 Jan 28;11(2):179. doi: 10.3390/pathogens11020179.
6
Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal Clusters in Africa To Inform Vaccine Development.系统评价和荟萃分析非洲 A 组链球菌群的流行情况，以为疫苗开发提供信息。
mSphere. 2020 Jul 15;5(4):e00429-20. doi: 10.1128/mSphere.00429-20.
7
strains associated with invasive and non-invasive infections present possible links with types and superantigens.与侵袭性和非侵袭性感染相关的菌株呈现出与类型和超抗原的可能联系。
Iran J Basic Med Sci. 2020 Jan;23(1):133-139. doi: 10.22038/IJBMS.2019.38635.9164.
8
Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town.开普敦地区非侵袭性和侵袭性 A 组链球菌感染的分子流行病学研究
mSphere. 2019 Oct 30;4(5):e00421-19. doi: 10.1128/mSphere.00421-19.
9
Clinical Screening Tools to Diagnose Group A Streptococcal Pharyngotonsillitis in Primary Care Clinics to Improve Prescribing Habits.基层医疗诊所中用于诊断A组链球菌性咽扁桃体炎以改善用药习惯的临床筛查工具。
Malays J Med Sci. 2018 Nov;25(6):6-21. doi: 10.21315/mjms2018.25.6.2. Epub 2018 Dec 28.
10
Streptococcal pharyngitis in children with painful throat: missed opportunities for rheumatic heart disease prevention in endemic area of Africa.非洲流行地区咽痛儿童的链球菌性咽炎：预防风湿性心脏病的错失良机。
Cardiovasc Diagn Ther. 2017 Aug;7(4):421-423. doi: 10.21037/cdt.2017.05.07.
本文引用的文献
1
Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.世界心脏联合会关于预防和控制风湿性心脏病的立场声明。
Nat Rev Cardiol. 2013 May;10(5):284-92. doi: 10.1038/nrcardio.2013.34. Epub 2013 Apr 2.
2
Potential coverage of a multivalent M protein-based group A streptococcal vaccine.基于多价 M 蛋白的 A 组链球菌疫苗的潜在覆盖范围。
Vaccine. 2013 Mar 15;31(12):1576-81. doi: 10.1016/j.vaccine.2013.01.019. Epub 2013 Jan 31.
3
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.新型 30 价 M 蛋白疫苗引发针对 A 组链球菌非疫苗血清型的交叉调理抗体。
Vaccine. 2011 Oct 26;29(46):8175-8. doi: 10.1016/j.vaccine.2011.09.005. Epub 2011 Sep 13.
4
Systematic Review: Estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis.系统评价：估计上呼吸道感染非化脓性后遗症（风湿热和链球菌感染后肾小球肾炎）的全球负担。
Trop Med Int Health. 2011 Jan;16(1):2-11. doi: 10.1111/j.1365-3156.2010.02670.x.
5
Rheumatic fever in indigenous Australian children.澳大利亚原住民儿童的风湿热
J Paediatr Child Health. 2010 Sep;46(9):527-33. doi: 10.1111/j.1440-1754.2010.01841.x.
6
Rheumatic heart disease in indigenous populations--New Zealand experience.风湿性心脏病在原住民中的流行情况——新西兰的经验。
Heart Lung Circ. 2010 May-Jun;19(5-6):282-8. doi: 10.1016/j.hlc.2010.02.021. Epub 2010 Apr 14.
7
Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study.城市中非洲成年人新发风湿性心脏病的发病情况和特点：来自索韦托心脏研究的见解。
Eur Heart J. 2010 Mar;31(6):719-27. doi: 10.1093/eurheartj/ehp530. Epub 2009 Dec 7.
8
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.A群链球菌的全球emm型分布：系统评价及对疫苗研发的启示
Lancet Infect Dis. 2009 Oct;9(10):611-6. doi: 10.1016/S1473-3099(09)70178-1.
9
Prevention and treatment of rheumatic heart disease in the developing world.发展中国家风湿性心脏病的预防与治疗。
Nat Rev Cardiol. 2009 Nov;6(11):689-98. doi: 10.1038/nrcardio.2009.162. Epub 2009 Sep 15.
10
The global burden of group A streptococcal diseases.A组链球菌疾病的全球负担。
Lancet Infect Dis. 2005 Nov;5(11):685-94. doi: 10.1016/S1473-3099(05)70267-X.
Zotero 插件